• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性硬脑膜下血肿的病因演变和手术治疗。

Chronic Subdural Hematoma-Evolution of Etiology and Surgical Treatment.

机构信息

Department of Neurosurgery, Kawasaki Medical School.

出版信息

Neurol Med Chir (Tokyo). 2023 Jan 15;63(1):1-8. doi: 10.2176/jns-nmc.2022-0207. Epub 2022 Oct 25.

DOI:10.2176/jns-nmc.2022-0207
PMID:36288974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9894619/
Abstract

In this paper, I review the historical changes in the etiological concepts and surgical treatments for chronic subdural hematoma (CSDH) across the world and in Japan. I also examine future problems associated with its surgical procedures and medical costs. CSDH was first reported by Wepfer in 1657 as "delayed apoplexy." In 1857, Virchow described the famous concept of so-called "pachymeningitis hemorrhagica interna." He considered that the etiology of CSDH involved inflammation. In 1914, Trotter described the origin of CSDH as traumatic. Currently, CSDH is considered to arise with a first leak of blood from dural border cells after mild trauma. Inflammatory cells are then drawn to the border cell layer. At this point, new membranes form from activated inflammation; then, the hematoma enlarges, promoted by angiogenic factors and new capillaries. In 1883, Hulke reported successful trepanning of a patient with CSDH. Burr holes and craniotomy for removal of the hematoma were subsequently reported, and new methods were developed over the course of several decades around the world. In Japan, after the first report by Nakada in 1938, many Japanese pioneering figures of neurological surgery have studied CSDH. After Mandai reported the middle meningeal artery embolization in 2000, this method is now considered useful as an initial or second treatment for CSDH. However, the age of patients is increasing, so more minimally invasive surgeries and useful pharmacotherapies are needed. We must also consider the costs for treating CSDH, because of the increasing numbers of surgical cases.

摘要

本文综述了慢性硬脑膜下血肿(CSDH)在世界和日本的病因概念和手术治疗的历史变化,并探讨了其手术程序和医疗费用相关的未来问题。CSDH 于 1657 年由 Wepfer 首次报道为“迟发性中风”。1857 年,Virchow 描述了所谓的“内硬脑膜出血性脑脊髓膜炎”的著名概念。他认为 CSDH 的病因涉及炎症。1914 年,Trotter 将 CSDH 的起源描述为创伤性的。目前,CSDH 被认为是在轻度创伤后,从硬脑膜边缘细胞首次漏出血液后发生的。然后,炎症细胞被吸引到边缘细胞层。此时,激活的炎症会形成新的膜;然后,在血管生成因子和新毛细血管的作用下,血肿增大。1883 年,Hulke 报道了一例 CSDH 患者成功颅骨切开术的病例。随后报道了颅骨钻孔和血肿切除术,在过去几十年中,世界各地都开发了新的方法。1938 年,Nakada 首次报道日本病例后,日本神经外科学的许多先驱人物都对 CSDH 进行了研究。2000 年 Mandai 报道了脑膜中动脉栓塞后,该方法现在被认为是 CSDH 的初始或二次治疗的有效方法。然而,患者的年龄在增加,因此需要更多的微创手术和有效的药物治疗。我们还必须考虑到治疗 CSDH 的成本,因为手术病例数量不断增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fee/9894619/790b8d675ea0/1349-8029-63-0001-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fee/9894619/41980c33acc2/1349-8029-63-0001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fee/9894619/790b8d675ea0/1349-8029-63-0001-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fee/9894619/41980c33acc2/1349-8029-63-0001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fee/9894619/790b8d675ea0/1349-8029-63-0001-g002.jpg

相似文献

1
Chronic Subdural Hematoma-Evolution of Etiology and Surgical Treatment.慢性硬脑膜下血肿的病因演变和手术治疗。
Neurol Med Chir (Tokyo). 2023 Jan 15;63(1):1-8. doi: 10.2176/jns-nmc.2022-0207. Epub 2022 Oct 25.
2
Which surgical procedure is effective for refractory chronic subdural hematoma? Analysis of our surgical procedures and literature review.哪种手术方法对难治性慢性硬膜下血肿有效?我们的手术方法分析及文献综述。
J Clin Neurosci. 2018 Mar;49:40-47. doi: 10.1016/j.jocn.2017.11.009. Epub 2017 Dec 20.
3
Sequential Middle Meningeal Artery Embolization after Burr Hole Surgery for Recurrent Chronic Subdural Hematoma.颅骨钻孔术后序贯-middle 脑膜动脉栓塞治疗复发性慢性硬脑膜下血肿。
Neurol Med Chir (Tokyo). 2023 Jan 15;63(1):17-22. doi: 10.2176/jns-nmc.2022-0164. Epub 2022 Oct 13.
4
Embolization of the middle meningeal artery in patients with chronic subdural hematoma-a systematic review and meta-analysis.慢性硬脑膜下血肿患者的脑膜中动脉栓塞治疗:系统评价和荟萃分析。
Acta Neurochir (Wien). 2020 Apr;162(4):777-784. doi: 10.1007/s00701-020-04266-0. Epub 2020 Feb 21.
5
Refractory Chronic Subdural Hematoma Associated with Dural Metastasis of Lung Adenocarcinoma Treated with Endovascular Embolization for the Middle Meningeal Artery: A Case Report and Review of the Literature.难治性慢性硬脑膜下血肿伴肺腺癌硬脑膜转移患者接受中脑膜动脉血管内栓塞治疗:病例报告及文献复习。
World Neurosurg. 2020 Jan;133:256-259. doi: 10.1016/j.wneu.2019.10.035. Epub 2019 Oct 16.
6
Hematoma cavity separation and neomembrane thickness are potential triggers of recurrence of chronic subdural hematoma.血肿腔分隔和新生膜厚度是慢性硬膜下血肿复发的潜在触发因素。
BMC Surg. 2022 Jun 20;22(1):236. doi: 10.1186/s12893-022-01687-9.
7
The efficacy and safety of burr-hole craniotomy without continuous drainage for chronic subdural hematoma and subdural hygroma in children under 2 years of age.2岁以下儿童慢性硬膜下血肿和硬膜下积液行钻孔开颅术不持续引流的疗效及安全性
Childs Nerv Syst. 2016 Dec;32(12):2369-2375. doi: 10.1007/s00381-016-3233-9. Epub 2016 Sep 9.
8
Arachnoid cyst is a risk factor for chronic subdural hematoma in juveniles: twelve cases of chronic subdural hematoma associated with arachnoid cyst.蛛网膜囊肿是青少年慢性硬膜下血肿的一个危险因素:12例与蛛网膜囊肿相关的慢性硬膜下血肿。
J Neurotrauma. 2002 Sep;19(9):1017-27. doi: 10.1089/089771502760341938.
9
Updates in Chronic Subdural Hematoma: Epidemiology, Etiology, Pathogenesis, Treatment, and Outcome.慢性硬脑膜下血肿的最新研究进展:流行病学、病因学、发病机制、治疗和预后。
World Neurosurg. 2020 Sep;141:339-345. doi: 10.1016/j.wneu.2020.06.140. Epub 2020 Jun 25.
10
Clinical Investigation of Refractory Chronic Subdural Hematoma: A Comparison of Clinical Factors Between Single and Repeated Recurrences.难治性慢性硬膜下血肿的临床研究:单次复发与反复复发的临床因素比较
World Neurosurg. 2017 Nov;107:706-715. doi: 10.1016/j.wneu.2017.08.101. Epub 2017 Aug 24.

引用本文的文献

1
Photon counting CT vs. flat-panel CT in the evaluation of enhancement patterns in chronic subdural hematoma after middle meningeal artery embolization.光子计数CT与平板CT在评估脑膜中动脉栓塞术后慢性硬膜下血肿强化模式中的应用比较
Front Neurol. 2025 May 16;16:1608308. doi: 10.3389/fneur.2025.1608308. eCollection 2025.
2
Factors Related to Recurrence and Complications after Percutaneous Subdural Tapping for Chronic Subdural Hematomas (Aoki Method): Clinical Experiences of 383 Patients with Chronic Subdural Hematomas.经皮硬膜下穿刺治疗慢性硬膜下血肿(青木法)后复发及并发症的相关因素:383例慢性硬膜下血肿患者的临床经验
Neurol Med Chir (Tokyo). 2025 Jun 15;65(6):263-270. doi: 10.2176/jns-nmc.2024-0224. Epub 2025 Apr 7.
3

本文引用的文献

1
Middle meningeal artery embolization for chronic subdural hematoma in cancer patients with refractory thrombocytopenia.脑膜中动脉栓塞术治疗合并难治性血小板减少症的癌症患者慢性硬膜下血肿
J Neurosurg. 2021 Oct 8;136(5):1273-1277. doi: 10.3171/2021.5.JNS21109. Print 2022 May 1.
2
Efficacy of endoscopic treatment for chronic subdural hematoma surgery.内镜治疗慢性硬脑膜下血肿手术的疗效。
J Clin Neurosci. 2021 Oct;92:78-84. doi: 10.1016/j.jocn.2021.07.058. Epub 2021 Aug 5.
3
History and current progress of chronic subdural hematoma.
Clinical effect and prognosis of laparoscopic surgery on colon cancer complicated with intestinal obstruction patients.
腹腔镜手术对结肠癌合并肠梗阻患者的临床疗效及预后
World J Gastrointest Surg. 2025 Mar 27;17(3):101609. doi: 10.4240/wjgs.v17.i3.101609.
4
Contralateral Progression after Unilateral Surgery for Bilateral Chronic Subdural Hematoma: A Prospective Observational Study.双侧慢性硬膜下血肿单侧手术后的对侧进展:一项前瞻性观察研究。
Neurol Med Chir (Tokyo). 2025 Apr 15;65(4):195-202. doi: 10.2176/jns-nmc.2024-0308. Epub 2025 Mar 21.
5
Efficacy of minimally invasive soft-channel drainage for chronic subdural hematoma utilizing 3D slicer: a retrospective comparative analysis.利用3D Slicer的微创软通道引流术治疗慢性硬膜下血肿的疗效:一项回顾性对比分析
Neurosurg Rev. 2024 Dec 24;48(1):1. doi: 10.1007/s10143-024-03147-9.
6
Chronic Subdural Hematoma in the Posterior Fossa Associated with Hearing Impairment during Warfarin Therapy, Improved by Middle Meningeal Artery Embolization: A Case Report.华法林治疗期间后颅窝慢性硬膜下血肿伴听力障碍,经脑膜中动脉栓塞改善:一例报告
NMC Case Rep J. 2024 Oct 24;11:291-296. doi: 10.2176/jns-nmc.2024-0138. eCollection 2024.
7
The clinical differences between traumatic and NOS chronic subdural hematoma.创伤性与非特定性慢性硬膜下血肿的临床差异。
Front Neurol. 2024 Oct 17;15:1453629. doi: 10.3389/fneur.2024.1453629. eCollection 2024.
8
The impact of renin-angiotensin-aldosterone system inhibitors on the recurrence of chronic subdural hematoma: a systematic review and meta-analysis.肾素-血管紧张素-醛固酮系统抑制剂对慢性硬脑膜下血肿复发的影响:系统评价和荟萃分析。
Neurosurg Rev. 2024 Oct 24;47(1):818. doi: 10.1007/s10143-024-03068-7.
9
Simultaneous and Consecutive Drainage of Bilateral Chronic Subdural Hematoma: A Randomized Controlled Trial.双侧慢性硬膜下血肿同期与序贯引流:一项随机对照试验
Neurol Med Chir (Tokyo). 2024 Dec 15;64(12):419-427. doi: 10.2176/jns-nmc.2024-0084. Epub 2024 Oct 22.
10
The pharmacological landscape of chronic subdural hematoma: a systematic review and network meta-analysis of randomized and non-randomized controlled studies.慢性硬膜下血肿的药理学概况:一项对随机和非随机对照研究的系统评价与网状荟萃分析
Burns Trauma. 2024 Sep 26;12:tkae034. doi: 10.1093/burnst/tkae034. eCollection 2024.
慢性硬脑膜下血肿的历史和现状。
J Neurol Sci. 2021 Oct 15;429:118066. doi: 10.1016/j.jns.2021.118066. Epub 2021 Sep 2.
4
[Hospital Discharge Arrangements for Very Elderly Patients with Chronic Subdural Hematoma].[老年慢性硬膜下血肿患者的出院安排]
No Shinkei Geka. 2020 Dec;48(12):1115-1120. doi: 10.11477/mf.1436204334.
5
Trial of Dexamethasone for Chronic Subdural Hematoma.地塞米松治疗慢性硬膜下血肿的试验。
N Engl J Med. 2020 Dec 31;383(27):2616-2627. doi: 10.1056/NEJMoa2020473. Epub 2020 Dec 16.
6
Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Multi-Center Experience of 154 Consecutive Embolizations.慢性硬膜下血肿的脑膜中动脉栓塞术:154例连续栓塞的多中心经验
Neurosurgery. 2021 Jan 13;88(2):268-277. doi: 10.1093/neuros/nyaa379.
7
Transradial middle meningeal artery embolization for chronic subdural hematoma using Onyx: case series.经桡动脉-middle meningeal artery 栓塞治疗慢性硬脑膜下血肿:病例系列。
J Neurointerv Surg. 2020 Dec;12(12):1214-1218. doi: 10.1136/neurintsurg-2020-016185. Epub 2020 Jun 29.
8
Updates in Chronic Subdural Hematoma: Epidemiology, Etiology, Pathogenesis, Treatment, and Outcome.慢性硬脑膜下血肿的最新研究进展:流行病学、病因学、发病机制、治疗和预后。
World Neurosurg. 2020 Sep;141:339-345. doi: 10.1016/j.wneu.2020.06.140. Epub 2020 Jun 25.
9
Chronic subdural hematoma-incidence, complications, and financial impact.慢性硬脑膜下血肿——发病率、并发症和经济影响。
Acta Neurochir (Wien). 2020 Sep;162(9):2033-2043. doi: 10.1007/s00701-020-04398-3. Epub 2020 Jun 10.
10
Systematic review of current randomised control trials in chronic subdural haematoma and proposal for an international collaborative approach.慢性硬脑膜下血肿随机对照试验的系统评价及国际协作方法的建议
Acta Neurochir (Wien). 2020 Apr;162(4):763-776. doi: 10.1007/s00701-020-04218-8. Epub 2020 Feb 6.